苏州开拓药业股份有限公司 KINTOR
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Kintor Pharma Collaborates with Etana to Commercialize Proxalutamide for Treatment of COVID-19 in Indonesia 2021-08-25 19:25
Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021 2021-08-24 17:04
Inclusion of Kintor as a Constituent Stock of HSCI 2021-08-23 08:44
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China 2021-07-28 13:47
Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay 2021-07-16 14:41
Kintor Pharmaceutical Collaborates with Fosun Pharma Development to Commercialise Proxalutamide for Treatment of COVID-19 in India and Africa 2021-07-15 10:00
Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne 2021-07-14 07:05
Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US 2021-07-11 21:03
Kintor Announced (1) FDA Has Greenlighted Proxalutamide's Phase III Study for Hospitalized Male and Female COVID-19 Patients to Be Conducted; and (2) Inclusion of Female Outpatients in Proxalutamide's Phase III Study for Mild to Moderate COVID-19 2021-05-20 09:47
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide 2021-04-16 18:29
Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China 2021-04-15 18:20
Kintor Pharmaceutical and Visum Announced Strategic Partnership to Expand Proxalutamide Manufacturing 2021-04-14 22:18
Kintor Pharmaceutical Limited Announces 2020 Business Progress and Annual Results 2021-03-26 20:54
Kintor Pharmaceutical Announces Results from Investigator-Initiated Brazil Trial Demonstrating 92% Reduction in Mortality in Hospitalized COVID-19 Patients 2021-03-11 14:54
Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA 2021-03-05 21:00
Completion of Patients' Recruitment for Proxalutamide's COVID-19 Hospitalised Study 2021-02-22 17:14
Kintor's GT20029 IND for PROTAC AR Degrader Was Accepted by NMPA 2021-02-02 12:11
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil 2021-01-28 19:57
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients 2021-01-10 16:55
Kintor Proxalutamide's COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates 2020-12-12 11:02
1 2 3 4